You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Olopatadine Hydrochloride

Showing 1 - 25 of 1,808
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A: Azelastine HCl 0.15% nasal spray (Azelair), Treatment B: Placebo

Recruiting
  • Seasonal Allergic Rhinitis
  • Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)
  • +2 more
  • Mississauga, Ontario, Canada
    Cliantha Research
Nov 6, 2023

Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes

Withdrawn
  • Allergic Rhinitis
  • Observational
  • Sydney, New South Wales, Australia
    Community and Patient Preference Research Pty Ltd
Mar 29, 2022

Bilateral Conjunctivitis (Disorder) Trial in Pompano Beach (Dexamethasone ophthalmic insert 0.4Mg, 0.2% loteprednol etabonate

Completed
  • Bilateral Conjunctivitis (Disorder)
  • Dexamethasone ophthalmic insert 0.4Mg
  • +2 more
  • Pompano Beach, Florida
    Clinical Research Center of Florida
Apr 6, 2022

Allergic Conjunctivitis Trial in Andover (olopatadine HCl ophthalmic solution 0.7%), Fluticasone Propionate, Tears Naturale)

Recruiting
  • Allergic Conjunctivitis
  • olopatadine hydrochloride ophthalmic solution 0.7%)
  • +3 more
  • Andover, Massachusetts
    Andover Eye Associates
Jul 18, 2022

Allergic Conjunctivitis Trial in Caba (Bepotastine Besilate 1.5% PF, Olopatadine Hydrochloride 0.2% BAK)

Recruiting
  • Allergic Conjunctivitis
  • Bepotastine Besilate 1.5% PF
  • Olopatadine Hydrochloride 0.2% BAK
  • Caba, Argentina
  • +3 more
Mar 29, 2021

Conjunctivitis, Allergic, Conjunctivitis, Vernal Trial in Montréal (Hyaluronic acid 0.05% & Ectoine 2.0%, Olopatadine HCl

Recruiting
  • Conjunctivitis, Allergic
  • Conjunctivitis, Vernal
  • Hyaluronic acid 0.05% & Ectoine 2.0%
  • Olopatadine hydrochloride ophthalmic solution 0.1%
  • Montréal, Quebec, Canada
    CHU Sainte-Justine Hospital
Oct 20, 2020

Allergic Conjunctivitis Trial (PRO-118, Olopatadine Hydrochloride)

Withdrawn
  • Allergic Conjunctivitis
  • (no location specified)
Oct 1, 2018

Vernal Keratoconjunctivitis, Cyclosporine 0.05% Eye Drops Trial in Nanchang (Cyclosporine 0.05% eye drops, Loteprednol Etabonate

Completed
  • Vernal Keratoconjunctivitis
  • Cyclosporine 0.05% Eye Drops
  • Cyclosporine 0.05% eye drops
  • Loteprednol Etabonate 0.5% and Tobramycin Eye Drops 0.3%
  • Nanchang, Jiangxi, China
    the Second Affiliated Hospital of Nanchang University
Apr 28, 2022

Seasonal Allergic Rhinitis Trial in United States (GSP 301-1 NS (QD), GSP 301-2 NS (BID), GSP 301 Placebo NS)

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • GSP 301-1 NS (QD)
  • +6 more
  • Austin, Texas
  • +9 more
Sep 28, 2020

Seasonal Allergic Rhinitis Trial in Mississauga (Molo 1 (also referred as GSP 301-2 NS), Molo 2 (also referred as GSP 301-1 NS),

Completed
  • Seasonal Allergic Rhinitis
  • Molo 1 (also referred as GSP 301-2 NS)
  • +4 more
  • Mississauga, Ontario, Canada
    Glenmark Investigational Site 1
Jun 18, 2018

Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)

Recruiting
  • Diabetic Peripheral Neuropathic Pain
  • HSK16149 20mg BID
  • Luoyang, Henan, China
    The First Affiliated Hospital of Henan University of Science and
Nov 2, 2023

Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)

Not yet recruiting
  • Laparoscopy
  • Anesthesia, Intravenous
  • Guangzhou, Guangdong, China
  • +11 more
Oct 15, 2023

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin

Not yet recruiting
  • Pain
  • Insomnia
  • Compound ibuprofen polyrelease tablets
  • reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Feb 6, 2023

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Propranolol
  • Propranolol hydrochloride
  • +2 more
  • (no location specified)
Jul 31, 2023

Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • Oral Topotecan Combined With Anlotinib
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023

Associated With Cardiomyopathy and Heart Failure After Cancer

Recruiting
  • Hodgkin Lymphoma in Remission
  • +6 more
  • Assessment of Therapy Complications
  • +3 more
  • Birmingham, Alabama
  • +78 more
Jan 11, 2023

Nalbuphine Allergy, Ablation, Safety Trial in China (Nalbuphine, Morphine)

Recruiting
  • Nalbuphine Allergy
  • +2 more
  • Hefei, Anhui, China
  • +19 more
Dec 28, 2022

Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)

Not yet recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablets
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Nov 9, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in

Active, not recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +8 more
  • 3-Dimensional Conformal Radiation Therapy
  • +8 more
  • Mobile, Alabama
  • +697 more
Nov 16, 2022

Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)

Recruiting
  • Nausea and Vomiting
  • Palonosetron hydrochloride capsules
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital, the Air Force Medical University
Jan 18, 2023

Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Carcinoma
  • Birmingham, Alabama
  • +806 more
Oct 18, 2022

Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)

Recruiting
  • Lymphoma, Solid Tumors
  • Mitoxantrone Hydrochloride Liposome
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2022

Oxycodone Sustained-release Tablets for Moderate to Severe

Recruiting
  • Cancer Pain
  • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 24, 2023